Stacker on MSN
New anxiety medications are in the pipeline for 2026
LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...
Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.
Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...
Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by ...
Some anxiety is part of the cost of admission to humanity. Because its distinguishing raison d’etre is the anticipation of bad outcomes, it can be a helpful stimulus to preparation or rehearsal before ...
Smartphone-based cognitive-behavioral therapy outperforms psychoeducation for generalized anxiety disorder, with benefits ...
In a world of constant connectivity and mounting pressures, generalized anxiety disorder (GAD) has emerged as a significant mental health challenge affecting millions. Recent studies show that anxiety ...
Scared Of on MSN
Phobias that are frequently mistaken for anxiety disorders
Ever felt your heart racing before a big presentation, or maybe butterflies in your stomach when meeting someone new? That's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback